Form 4: RxSight Executive Ilya Goldshleger Exercises Options and Sells Shares

Ilya Goldshleger, Co-President and COO of RxSight, Inc., executed stock options and sold shares of common stock between September 20 and September 23, 2024, according to a Form 4 filing with the SEC.

Summary

• Ilya Goldshleger, Co-President and Chief Operating Officer of RxSight, Inc., filed a Form 4 with the SEC.
• On September 20 and 23, 2024, Goldshleger exercised stock options to acquire 3,100 shares each day at a price of $15.08 per share.
• Concurrently, Goldshleger sold shares of common stock on the same days.
• On September 20, 2024, 3,100 shares were sold at a weighted average price of $53.1939, with prices ranging from $52.85 to $53.68.
• On September 23, 2024, 2,950 shares were sold at a weighted average price of $52.6215 (range: $52.31 to $53.24) and 150 shares were sold at $53.53.
• Following these transactions, Goldshleger directly owns 42,246 shares of common stock and indirectly owns 1,372 shares through a spouse.
• He also holds options to purchase 105,907 shares of common stock.
• The sales were executed under a Rule 10b5-1 trading plan adopted on June 3, 2024.

Sentiment

Score: 5

Explanation: The document is a routine disclosure of stock transactions by an executive. It doesn't inherently convey positive or negative sentiment about the company's performance or prospects. The use of a 10b5-1 plan suggests pre-planned transactions, reducing the likelihood of the sales being driven by immediate concerns about the company.

Industry Context

Executive stock transactions are common and are often scrutinized by investors for insights into management's perspective on the company's future prospects. Rule 10b5-1 plans are designed to allow insiders to trade without being accused of trading on non-public information.

Comparison to Industry Standards

• Executive compensation packages in the medical device industry often include stock options to align management's interests with those of shareholders.
• The vesting schedule of the options (1/48th per month) is a fairly standard practice.
• Sales under a 10b5-1 plan are a common way for executives to diversify their holdings and manage personal finances.

Stakeholder Impact

• The transactions may have a minor impact on shareholders, potentially creating slight downward pressure on the stock price due to the sales.
• The executive's actions could be interpreted as a lack of confidence, although the 10b5-1 plan mitigates this concern.

Key Dates